These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 28092842

  • 1. Blocking TGF-β1 by P17 peptides attenuates gastric cancer cell induced peritoneal fibrosis and prevents peritoneal dissemination in vitro and in vivo.
    Lv ZD, Zhao WJ, Jin LY, Wang WJ, Dong Q, Li N, Xu HM, Wang HB.
    Biomed Pharmacother; 2017 Apr; 88():27-33. PubMed ID: 28092842
    [Abstract] [Full Text] [Related]

  • 2. Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis.
    Lv ZD, Na D, Liu FN, Du ZM, Sun Z, Li Z, Ma XY, Wang ZN, Xu HM.
    J Exp Clin Cancer Res; 2010 Oct 29; 29(1):139. PubMed ID: 21034459
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Transforming growth factor beta1 produced in autocrine/paracrine manner affects the morphology and function of mesothelial cells and promotes peritoneal carcinomatosis.
    Na D, Lv ZD, Liu FN, Xu Y, Jiang CG, Sun Z, Miao ZF, Li F, Xu HM.
    Int J Mol Med; 2010 Sep 29; 26(3):325-32. PubMed ID: 20664947
    [Abstract] [Full Text] [Related]

  • 5. TGF-β1 induces peritoneal fibrosis by activating the Smad2 pathway in mesothelial cells and promotes peritoneal carcinomatosis.
    Lv ZD, Wang HB, Li FN, Wu L, Liu C, Nie G, Kong B, Qu HL, Li JG.
    Int J Mol Med; 2012 Mar 29; 29(3):373-9. PubMed ID: 22139024
    [Abstract] [Full Text] [Related]

  • 6. Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo.
    Lv ZD, Wang HB, Dong Q, Kong B, Li JG, Yang ZC, Qu HL, Cao WH, Xu HM.
    Mol Cell Biochem; 2013 May 29; 377(1-2):177-85. PubMed ID: 23392771
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
    Peng Y, Liu H, Liu F, Liu Y, Li J, Chen X.
    Nephrology (Carlton); 2006 Dec 29; 11(6):516-23. PubMed ID: 17199790
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta1 signaling blockade attenuates gastric cancer cell-induced peritoneal mesothelial cell fibrosis and alleviates peritoneal dissemination both in vitro and in vivo.
    Miao ZF, Zhao TT, Wang ZN, Miao F, Xu YY, Mao XY, Gao J, Wu JH, Liu XY, You Y, Xu H, Xu HM.
    Tumour Biol; 2014 Apr 29; 35(4):3575-83. PubMed ID: 24347485
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T, Nishimura H, Mizuno M, Suzuki Y, Matsukawa Y, Sakata F, Maruyama S, Takei Y, Ito Y.
    Am J Physiol Renal Physiol; 2018 Feb 01; 314(2):F167-F180. PubMed ID: 28978530
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. PDCD4 regulates apoptosis in human peritoneal mesothelial cells and promotes gastric cancer peritoneal metastasis.
    Wu P, Wang J, Mao X, Xu H, Zhu Z.
    Histol Histopathol; 2021 Apr 01; 36(4):447-457. PubMed ID: 33442866
    [Abstract] [Full Text] [Related]

  • 16. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
    Jiang N, Zhang Z, Shao X, Jing R, Wang C, Fang W, Mou S, Ni Z.
    J Cell Physiol; 2020 Jan 01; 235(1):364-379. PubMed ID: 31236971
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
    Zhang Y, Huang Q, Chen Y, Peng X, Wang Y, Li S, Wu J, Luo C, Gong W, Yin B, Xiao J, Zhou W, Peng F, Long H.
    Int Immunopharmacol; 2020 Jan 01; 78():106064. PubMed ID: 31838448
    [Abstract] [Full Text] [Related]

  • 19. Connective tissue growth factor is a positive regulator of epithelial-mesenchymal transition and promotes the adhesion with gastric cancer cells in human peritoneal mesothelial cells.
    Jiang CG, Lv L, Liu FR, Wang ZN, Na D, Li F, Li JB, Sun Z, Xu HM.
    Cytokine; 2013 Jan 01; 61(1):173-80. PubMed ID: 23073116
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.